Adaptimmune Therapeutics
ADAP
#9234
Rank
S$96.05 M
Marketcap
$0.36
Share price
4.45%
Change (1 day)
-76.87%
Change (1 year)

Adaptimmune Therapeutics (ADAP) - P/B ratio

P/B ratio as of April 2025 : 6.20

According to Adaptimmune Therapeutics's latest financial reports the company has a price-to-book ratio of 0.412444.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Adaptimmune Therapeutics - P/B ratio (from 2015 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-3112.7179.52%
2023-12-314.5656.03%
2022-12-312.922.72%
2021-12-312.8416.32%
2020-12-312.45139.54%
2019-12-311.02-58.09%
2018-12-312.44-21%
2017-12-313.0878.68%
2016-12-311.73-49.33%
2015-12-313.41
2014-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
-1.83-129.57%๐Ÿ‡บ๐Ÿ‡ธ USA
0.3528-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
-113-1,915.67%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
4.72-23.83%๐Ÿ‡บ๐Ÿ‡ธ USA